Interaction of antihistaminic drugs with human translationally controlled tumor protein (TCTP) as novel approach for differentiation therapy

Translationally controlled tumor protein (TCTP) represents an exquisite target for cancer differentiation therapy, because it was most strikingly down-regulated in tumor reversion experiments. Since TCTP is identical with the histamine releasing factor, antihistamic drugs may inhibit TCTP. Indeed, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Ean-Jeong, Efferth, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941353/
https://www.ncbi.nlm.nih.gov/pubmed/26921194
http://dx.doi.org/10.18632/oncotarget.7605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941353/
https://www.ncbi.nlm.nih.gov/pubmed/26921194
http://dx.doi.org/10.18632/oncotarget.7605

Ejemplares similares